Victory Capital Management Inc. raised its holdings in InMode Ltd. (NASDAQ:INMD – Get Rating) by 3.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 639,613 shares of the healthcare company's stock after acquiring an additional 18,622 shares during the quarter. Victory Capital Management Inc.'s holdings in InMode were worth $18,619,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the business. Crossmark Global Holdings Inc. acquired a new position in InMode in the third quarter valued at approximately $252,000. Baltimore Washington Financial Advisors Inc. increased its holdings in shares of InMode by 3.2% during the third quarter. Baltimore Washington Financial Advisors Inc. now owns 297,579 shares of the healthcare company's stock valued at $8,661,000 after acquiring an additional 9,235 shares in the last quarter. Meitav Dash Investments Ltd. increased its holdings in shares of InMode by 13.8% during the third quarter. Meitav Dash Investments Ltd. now owns 1,631,056 shares of the healthcare company's stock valued at $46,922,000 after acquiring an additional 197,271 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. increased its holdings in shares of InMode by 15.1% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 837,300 shares of the healthcare company's stock valued at $24,374,000 after acquiring an additional 110,000 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D increased its holdings in shares of InMode by 85.3% during the third quarter. State of New Jersey Common Pension Fund D now owns 139,924 shares of the healthcare company's stock valued at $4,073,000 after acquiring an additional 64,406 shares in the last quarter. 55.24% of the stock is owned by institutional investors and hedge funds.
Get InMode alerts:InMode Trading Down 0.3 %
Shares of InMode stock opened at $34.62 on Thursday. The stock has a fifty day simple moving average of $35.67 and a 200 day simple moving average of $33.48. InMode Ltd. has a 12-month low of $20.60 and a 12-month high of $54.68. The company has a market capitalization of $2.88 billion, a P/E ratio of 16.72 and a beta of 2.19.
InMode (NASDAQ:INMD – Get Rating) last posted its quarterly earnings data on Thursday, October 27th. The healthcare company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.63 by ($0.05). InMode had a return on equity of 39.52% and a net margin of 40.93%. The business had revenue of $121.23 million during the quarter, compared to analysts' expectations of $120.70 million. On average, analysts predict that InMode Ltd. will post 2.17 EPS for the current year.Analysts Set New Price Targets
Several equities research analysts have recently commented on INMD shares. Barclays initiated coverage on InMode in a report on Wednesday, December 21st. They set an "overweight" rating and a $44.00 price objective for the company. Jefferies Financial Group initiated coverage on InMode in a report on Wednesday, October 12th. They set a "buy" rating and a $40.00 price target for the company. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $46.17.
InMode Company Profile
(Get Rating)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Featured Articles
- Get a free copy of the StockNews.com research report on InMode (INMD)
- AMD Is Still One Of The Best Semiconductor Stocks Out There
- Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMD – Get Rating).
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.